- AbbVie Q3 global IMBRUVICA revenue $522M
- AbbVie reported third-quarter global IMBRUVICA revenue of $522 million.
AbbVie reported $522 million in global IMBRUVICA revenue for the third quarter. The figure is a component of AbbVie's broader Q3 earnings and will be weighed against expectations.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.